Bronchial Asthma and Diabetes: Impact on Bronchial Inflammation and Exercise Capacity
Sponsor: Galmarini Hospital, Tradate
Terminated
technical issue
This observational or N/A phase trial investigates Asthma and Diabete Type 2 and is currently terminated or withdrawn. Galmarini Hospital, Tradate leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Mar 2024 — Jul 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Feb 2024 — Mar 2024 [monthly]
Active Not Recruiting
-
Nov 2022 — Feb 2024 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Apr 2022 — Nov 2022 [monthly]
Active Not Recruiting
-
Jun 2021 — Apr 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Galmarini Hospital, Tradate
- Istituti Clinici Scientifici Maugeri SpA
For direct contact, visit the study record on ClinicalTrials.gov .